Document is current

Article History

Received: 6 January 2024

Accepted: 27 March 2024

First Online: 3 May 2024

Competing interests

: Lara McKenzie and Samantha Carlson have no conflicts of interest to declare. Christopher Blyth was a member of the Australian Technical Advisory Group on Immunisation (ATAGI; 2012-2021), leading the development and implementation of Australia’s COVID-19 vaccination program. In addition, he is appointed to the Commonwealth Government’s COVID-19 Vaccines and Treatments for Australia Science and Industry Technical Advisory Group (SITAG; 2020-2023). He is a current recipient of a National Health and Medical Research Council (NHMRC) Investigator award (APP1173163). Katie Attwell is a specialist advisor to the ATAGI COVID-19 working group. She is a current recipient of a Discovery Early Career Researcher Award funded by the Australian Research Council of the Australian Government (DE19000158). <i>Coronavax</i> is funded through a Wesfarmers Centre of Vaccines and Infectious Diseases Catalyst grant, a Future Health Research & Innovation Fund COVID-19 Focus Grant, and by the Western Australian Department of Health.

: This project has ethical approval from the Child and Adolescent Health Services Human Research Ethics Committee (HREC) under permit number RGS0000004457. The University of Western Australia (UWA) HREC reciprocally recognised this approval under permit number 2020/ET000339, and separately granted ethical approval for the federal functional dialogues under permit number 2020/ET000340.

: All interviews were provided with an information sheet and signed a consent form prior to the interview.